Blend Labs director proposes sale of 22,523 shares

The notice lists earlier sales on September 14 and September 21, 2026, with gross proceeds of $25,267.00 and $25,024.00.

Rhea-AI Filing Summary

Blend Labs, Inc. officer and director Nima Ghamsari reported a proposed sale of 22,523 common shares, with an aggregate market value of $24,816.00 and an approximate sale date of September 28, 2026. Charles Schwab & Co., Inc. is listed as broker. The shares were acquired through a restricted stock lapse on November 20, 2025. The notice also lists earlier sales of 17,731 shares for $25,267.00 on September 14, 2026, and 21,009 shares for $25,024.00 on September 21, 2026.

Key Figures

Shares proposed for sale: 22,523 shares Aggregate market value: $24,816.00 Shares outstanding: 233,256,934 shares +4 more

7 metrics

Shares proposed for sale 22,523 shares Proposed sale of common shares

Aggregate market value $24,816.00 Proposed sale

Shares outstanding 233,256,934 shares Issuer shares outstanding reported in the notice

Shares sold 17,731 shares Sale on September 14, 2026

Gross proceeds $25,267.00 Sale on September 14, 2026

Shares sold 21,009 shares Sale on September 21, 2026

Gross proceeds $25,024.00 Sale on September 21, 2026

Key Terms

Rule 144, Restricted Stock Lapse, aggregate market value

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Lapse financial

"Nature of acquisition transaction: Restricted Stock Lapse"

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BLND shares is Nima Ghamsari proposing to sell?

Nima Ghamsari reported a proposed sale of 22,523 Blend Labs, Inc. common shares, with an aggregate market value of $24,816.00 and an approximate sale date of September 28, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 04:03 PM Accepted by SEC EDGAR 09/28/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001870974
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Blend Labs, Inc.
SEC File Number	001-40599
Address of Issuer	7250 REDWOOD BLVD., SUITE 300 NOVATO CALIFORNIA 94945
Phone	(650) 550-4810
Name of Person for Whose Account the Securities are To Be Sold	Ghamsari Nima
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	22523	24816.00	233256934	09/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Restricted Stock Lapse	BLEND LABS, INC.			22523	11/20/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NIMA GHAMSARI 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 76262	Blend Labs, Inc.	09/14/2026	17731	25267.00
NIMA GHAMSARI 7250 REDWOOD BLVD., SUITE 300 NOVATO CA 76262	Blend Labs, Inc.	09/21/2026	21009	25024.00

144: Remarks and Signature

Remarks
Date of Notice	09/28/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	NIMA GHAMSARI
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)